Alfred Altomari, Chief Executive Officer at AGILE THERAPEUTICS INC (AGRX), bought 26,541 shares at $2.71 ($39K) on 2020-02-27, disclosed to the SEC on 2020-02-27.
Seasonal purchase ($39k) by Chief Executive Officer — this insider has traded AGRX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.71 | 16,541 | $12K | 30.2% |
| 2 | $2.71 | 10,000 | $27K | 69.8% |
| Total | $1.46 avg | 26,541 | $39K | 100% |
| Filing → |
| AGRX | BUY | 2021-05-19 | $32K | — | Filing → |
| AGRX | BUY | 2021-03-23 | $25K | — | Filing → |
| INSM | SELL | 2020-12-09 | $791K | — | Filing → |